Pfizer Investment Enter (pfe 4.75 05/19/33)
13F holders, Q2 2026 (June 30)2holders +1
1new positions
0sold out
$0.99avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Pfizer Investment Enter (pfe 4.75 05/19/33) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Vermillion Wealth Management, Inc. ($46K) and Financial Gravity Companies, Inc. ($4K).
- Company
- Pfizer Investment Enter (pfe 4.75 05/19/33)
- CUSIP
- 716973AE2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $46K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q2 2026: 47,000 shares bought, net +47,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Vermillion Wealth Management, Inc. | 0.01% | New | 47,000 | $46K |
| Financial Gravity Companies, Inc. | 0.00% | — | 4,000 | $4K |
"% of holder's portfolio" is PFIZER INVESTMENT ENTER (PFE 4.75 05/19/33)'s weight in each manager's 13F, not the share of Pfizer Investment Enter (pfe 4.75 05/19/33) the manager owns.